Circulating Levels of Adipokines Predict the Occurrence of Acute Graft-versus-host Disease.
- Author:
Jin Sook KIM
1
;
Da Bin YOU
;
Ji Young LIM
;
Sung Eun LEE
;
Yoo Jin KIM
;
Hee Je KIM
;
Nack Gyun CHUNG
;
Chang Ki MIN
Author Information
- Publication Type:Original Article
- Keywords: Adipokines; Acute graft-versus-host disease; Allogeneic stem cell transplantation
- MeSH: Adipokines*; Angiopoietin-2; Graft vs Host Disease*; Hepatocyte Growth Factor; Humans; Kinetics; Pilot Projects; Protein Array Analysis; Resistin; Stem Cell Transplantation
- From:Immune Network 2015;15(2):66-72
- CountryRepublic of Korea
- Language:English
- Abstract: Currently, detecting biochemical differences before and after allogeneic stem cell transplantation (SCT) for improved prediction of acute graft-versus-host disease (aGVHD) is a major clinical challenge. In this pilot study, we analyzed the kinetics of circulating adipokine levels in patients with or without aGVHD before and after allogeneic SCT. Serum samples were obtained and stored at -80degrees C within 3 hours after collection, prior to conditioning and at engraftment after transplantation. A protein array system was used to measure the levels of 7 adipokines of patients with aGVHD (n=20) and without aGVHD (n=20). The resistin level at engraftment was significantly increased (p<0.001) after transplantation, regardless of aGVHD occurrence. In the non-aGVHD group, the concentrations of the hepatocyte growth factor (HGF) (mean values+/-SD; 206.6+/-34.3 vs. 432.3+/-108.9 pg/ml, p=0.040) and angiopoietin-2 (ANG-2) (mean values+/-SD; 3,197.2+/-328.3 vs. 4,471.8+/-568.4 pg/ml, p=0.037) at engraftment were significantly higher than those of the pre-transplant period, whereas in the aGVHD group, the levels of adipokines did not change after transplantation. Our study suggests that changes in serum HGF and ANG-2 levels could be considered helpful markers for the subsequent occurrence of aGVHD.
